Friday, November 2, 2018

Investorideas.com - Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSXV: $OGO.V, TSX: $WEED.TO, NYSE: $CGC, TSX: $APHA.TO, NYSE: $APHA, CSE: $CXXI.C

Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSXV: $OGO.V, TSX: $WEED.TO, NYSE: $CGC, TSX: $APHA.TO, NYSE: $APHA, CSE: $CXXI.C

Delta, Kelowna, BC - November 2, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of its series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2018/110218-StocksToWatch.mp3

Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSXV: $OGO.V, TSX: $WEED.TO, NYSE: $CGC, TSX: $APHA.TO, NYSE: $APHA, CSE: $CXXI.C

Hear Investor ideas cannabis potcast on iTunes

Today's podcast overview/transcript:

From company news sources

Good afternoon and welcome to another Investorideas.com Potcast - following Cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today we will be looking at announcements from Organto Foods Inc. trading on the TSX-Venture as OGO and OTC as OGOFF, Canopy Growth Corporation trading on the TSX as WEED and the NYSE as CGC, Aphria Inc.trading on the TSX and NYSE as APHA and C21 Investments Inc. trading on the CSE as CXXI

Organto Foods Inc., an integrated provider of value-added organic vegetables and fruits today announces that it has entered into an agreement to acquire Medicannabis S.A.S. ("Medicannabis"), a privately held Colombian medicinal cannabis company that is a late stage applicant for licenses to enable it to cultivate and process cannabis in Colombia.

"We believe the acquisition of Medicannabis is a logical and complementary extension to our current organic vegetables and fruits business, given our diverse sourcing, processing, logistics, import, export and organic certification expertise." commented Steve Bromley, Chair and Interim Chief Executive Officer of Organto Foods Inc. "While organic fruits and vegetables will continue to be the mainstay of our business, we believe the addition of a self-standing cannabis division will ultimately lead to increased profitability and value creation for our shareholders."

Under the terms of the agreement, the transaction would proceed in two stages. In the first stage Organto acquires the shares of Medicannabis and undertakes the final stages of the licensing process. Subject to final due-diligence, this is anticipated to be completed during the week of November 5, 2018. In the second stage, which remains subject to the acceptance of the TSX Venture Exchange and shareholder approval, Organto issues up to 8,000,000 shares (the "Shares") to the original shareholders of Medicannabis upon receipt of a cultivation license which is one of a number of licenses Medicannabis has applied for. Should the transaction proceed, Organto will seek shareholder approval via shareholder consent resolutions, and is confident this can be obtained in a timely manner. The Shares would be subject to a four month hold period under applicable securities regulation and also be subject to contractual release limitations over a three-year period.

Full details of the acquisition, including Organto's plans in the cannabis sector, Medicannabis' unique cultivar breeds, and key personnel appointments, will be announced following closing, should it proceed, and is currently scheduled for the week of November 5, 2018.

Constellation Brands, Inc. (NYSE: STZ) and Canopy Growth Corporation announced the closing of Constellation's $5 billion CAD ($4 billion USD) investment in Canopy Growth, which was previously announced on August 15, 2018. The transaction was approved by an overwhelming majority of Canopy Growth shareholders and has been granted all required regulatory approvals, including by the Canadian government under the Investment Canada Act.

This investment provides Canopy Growth with significant funding needed to build scale in the more than 30 countries currently pursuing federally permissible medical cannabis programs, while establishing the foundation needed to supply new recreational adult-use markets as cannabis becomes legal in markets around the world.

"We're excited to expand our strategic partnership with Canopy Growth and to begin helping them build the global scale needed to win long-term," said Rob Sands, chief executive officer, Constellation Brands. "The global cannabis market presents a significant growth opportunity and Canopy Growth is well-positioned to establish a strong leadership position in this fast-evolving category."

Aphria Inc., who began trading on the NYSE under the new symbol APHA today, also announced that its Australian-based partner Althea Company Pty Ltd. has been granted a Manufacture Licence by the Australian Government's Office of Drug Control.

The license provides Althea with authorization to manufacture extracts and tinctures of cannabis and cannabis resin in accordance with relevant manufacture permits.

"We are excited to see our Australian partner achieve yet another milestone in receiving its Manufacture License. This is another step towards ensuring Australian patients have access to high-quality medicinal cannabis," said Vic Neufeld, CEO of Aphria.

C21 Investments Inc. announced that it has entered into definitive agreements for the July 9, 2018 announced acquisition of Swell Companies Limited. Swell is an extraction, manufacturer and distributor of THC and CBD products. Swell has more than 50 of its branded products available in over 275 licensed retail locations across Oregon. Raw oil, encapsulates and vaporizers are distributed under its in-house brands: Dab Society Extracts and Hood Oil. The capacity of Swell's Portland processing facility will reach up to 5,000 lbs of raw material throughput a month. This throughput will translate into 220,000 to 270,000 grams of processed high-quality oil-based extracts per month, making Swell one of the largest processing groups in Oregon. Additionally, a new state of the art facility located in Bend, Oregon, will be operational in December adding a further capacity to process 1,200 lbs of raw material per month delivering a further 65,000 grams of processed high-quality extracts monthly.

"Swell is C21 Investment's 4th US operation within its asset portfolio to sign a definitive agreement," said Robert Cheney, President and CEO of C21 Investments. "Acquiring Swell fulfills a critical segment in the Company's expansion strategy making C21 Investments a leading force in processing and manufacturing in the United States.

"Consumption of cannabis concentrates, such as vapes and edibles, saw a 49%1 increase in 2018," said Alleh Lindquist, CEO of Swell. "This segment is quickly becoming the most significant component in cannabis consumption and with the support of C21, Swell will have the necessary resources to further expand its extraction and manufacturing capabilities to new markets

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

Subscribe to the new cannabis podcast series:

https://www.investorideas.com/rss/feeds/Podcasts-Cannabis.xml

Or visit https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column and the Cleantech and Climate Change Podcast.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

Contact Investorideas.com

800-665-0411

Investorideas.com - Innovative #Cannabis Delivery Technologies on the Rise: The Greater Cannabis Company, Inc. (OTC: $GCAN), Aphria (TSX: $APHA.TO) (NYSE: $APHA), Tilray ( $TLRY), Aurora (TSX: $ACB.TO) (NYSE: $ACB) and Canopy Growth (TSX: $WEED.TO) (NYSE: $CGC)

Investorideas.com - Innovative #Cannabis Delivery Technologies on the Rise: The Greater Cannabis Company, Inc. (OTC: $GCAN), Aphria (TSX: $APHA.TO) (NYSE: $APHA), Tilray ( $TLRY), Aurora (TSX: $ACB.TO) (NYSE: $ACB) and Canopy Growth (TSX: $WEED.TO) (NYSE: $CGC)

Innovative #Cannabis Delivery Technologies on the Rise: The Greater Cannabis Company, Inc. (OTC: $GCAN), Aphria (TSX: $APHA.TO) (NYSE: $APHA), Tilray ( $TLRY), Aurora (TSX: $ACB.TO) (NYSE: $ACB) and Canopy Growth (TSX: $WEED.TO) (NYSE: $CGC)

Point Roberts, WA and Kelowna, BC - November 2, 2018 (Investorideas.com Newswire) Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks releases a sector snapshot with a focus on new and innovative delivery systems coming to market.

Through the month of September, larger Canadian cannabis companies including Aphria Inc. (TSX: APHA.TO), which commences trading on the NYSE today (NYSE: APHA), have been investing heavily in new cannabis delivery systems. These technologies have the ability to afford consumers a safer alternative to other routes of cannabinoid delivery, many of which have detrimental health effects.

The global trend is in play in the U.S as well. This past Wednesday, The Greater Cannabis Company, Inc. (OTC: GCAN), a biopharmaceutical company focused on development and commercialization of innovative delivery systems for the Cannabis market, announced "the completion of development and reformulation of its eluting patch (EPP) for cannabinoid use. The EPP has been successfully developed in the past for pharmaceutical and over the counter (OTC) products, as well as for oral health applications. In preparation for commercializing cannabinoid products, the Company completed extensive testing of its new formulations. The cannabinoid transmucosal patch was found to have additional benefits over those previously mentioned, and which can be found on the Company's website. GCAN's product allows consumers to absorb cannabinoids through the vascular buccal mucosa (cheek) directly into the bloodstream, and bypass the GI tract. They look like Listerine fresh breath strips, but instead of melting in your mouth right away they have bioadhesive properties that allow the thin films to unobtrusively stick to the inside of your mouth. The cannabinoid actives loaded on the thin films absorb through the very vascular oral cavity and go right into the bloodstream. The unique delivery system also has a mechanism that allows for an initial rapid release of CBD/THC followed by a slow and gradual release of the cannabinoids on subsequent layers of the same thin film. The intent behind the fully dissolvable patch is to offer consumers a needle-free systemic delivery of cannabinoids, while effectively bypassing the digestive and hepatic systems, and without the side effects typically found with smoking or vaping."

"The Company has entered into a new stage of aggressively ramping up its efforts to commercialize the technology through sublicensing and joint venture agreements. Target partners include licensed producers and dealers in the United States, Canada and abroad, as well as pharmaceutical companies focused on cannabinoids therapies."

According to the company's news - "New delivery systems are making their way into the industry. By way of example - the industry is fast adopting similar delivery technologies as seen in recent transactions."

Standardized and controlled dosing is driving cannabis companies strategic direction, and what may been fueling many of these delivery system transactions. This new and innovative U.S. company (OTC: GCAN) is correct and right on the money in not only seeing the trend, but participating in it.

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB.TO ) announced it acquired an equity stake in CTT Pharmaceutical Holdings Inc. back in September of this year, converting the $1,000,000 USD/5% debenture into equity shares of CT, giving an approximate 9.14% equity ownership stake in CTT while still holding a warrant which enables Aurora to increase its equity ownership to 42.5%. CTT's principal asset is a unique and novel patented drug delivery technology, an orally administered, fast-dissolving, thin film (the "Wafer"). This technology platform will target both the human and veterinary (pet) markets for treatment of many diseases. The Company believes that its Wafer technology will be one of the first to gain use in major markets such as pain management. Several Canadian and U.S. patents protect the Oral Thin Film (Wafer) formulation.

From the news, "CTT's oral fast dissolving drug delivery systems consist of edible Wafers that dissolve without water and within a few seconds after placement in the mouth. The majority of drugs administered using our drug delivery system mirror injections in that they have the ability to enter the bloodstream quickly, are convenient and discrete, and can be administered anywhere. A faster absorption rate is achieved because the mouth contains a very thin mucosa and is extremely vascular. There is no smoke inhalation, less degradation of medication (by bypassing the stomach) and most importantly lower dosage units are required given the efficacy of absorption. Patient compliance is also improved especially with those who have a fear of choking or difficulty swallowing, and/or are pediatric, geriatric or incapacitated."

Also in September, IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) announced that it had executed a non-binding letter of intent with Tilray, Inc.( NASDAQ: TLRY) to co-develop and commercialize oral film products infused with recreational and medical cannabis ("cannabis-infused VersaFilm™"), in anticipation of amended cannabis regulations which would allow adult-use consumers to purchase edible products.

"Through the company's work on VersaFilm with Tilray, IntelGenx Corp has also developed new products out of this technology, specifically RIZAPORT. The company recently announced that its commercialization partner for RIZAPORT® (10mg) in Spain, Groupo Juste, which is now part of Exceltis Healthcare, has received national marketing authorization from the Spanish Agency of Medicines and Medical Devices (AEMPS) for the product."

"RIZAPORT® is a proprietary oral thin film formulation of rizatriptan for the treatment of acute migraines. RIZAPORT® offers an innovative and potentially advantageous therapeutic alternative for many migraine patients, primarily patients who suffer from dysphagia or migraine-related nausea, due to its convenient dosing, facile intake due to the lack of need for water, and neutral flavor."

Continuing that same September delivery trend, CURE Pharmaceutical (OTC: CURR) announced that "it entered into a multi-year licensing agreement for the first time with a leading international cannabis company, Canopy Growth (NYSE: CGC) (TSX: WEED.TO). Under the terms of the agreement, the cannabis company will have an exclusive license to CURE's patented, multi-layer oral thin film (OTF) CUREfilm technology for use with cannabis extracts and biosynthetic cannabinoids in markets around the world."

"Whole plant extracted, biosynthesized and synthetic cannabinoids all hold therapeutic promise for given indications and intended uses," said Rob Davidson, CEO and chairman of CURE Pharmaceutical. "At CURE, we focus on synthetic cannabinoids for CUREfilm products, but with our new licensing business model, we will expand the impact and applications of our technology to these other promising approaches by partnering with an industry leader in this market."

Aphria Inc. (TSX: APH) (NYSE: APHA) was no exception to the move of big cannabis companies buying into cannabis delivery systems. Aphria and Rapid Dose Therapeutics Inc ., a Canadian bio-technology company focused on innovative drug delivery solutions, announced as well in September that they have "signed a non-binding Memorandum of Understanding related to RDT's QuickStrip™ products. Under the terms of the MOU, the companies intend to enter into a definitive agreement in the near future pursuant to which RDT will provide Aphria with exclusive global preferred rights to produce, distribute and sell QuickStrip™ products for cannabis markets around the world."

According to their news, "Aphria is committed to bringing breakthrough innovations to the global cannabis market, which is why we are excited to introduce RDT as a strategic innovation partner," said Jakob Ripshtein, Chief Commercial Officer at Aphria. "They have developed a truly innovative product that will offer both patients and consumers a new way to consume and experience cannabis. We eagerly anticipate launching QuickStrip™ delivery technology across our portfolio of medical and adult-use brands and look forward to extending this valuable partnership to other markets around the world."

Seeing the amount of deal flow in the sector, the CEO is ramping up the roll-out for The Greater Cannabis Company, Inc. (OTC: GCAN). The Company's sole focus now is to bring its licensed technology to market. "The technology has the ability to afford consumers a safer alternative to other routes of cannabinoid delivery, many of which have detrimental health effects. As part of its strategic initiative, the Company is seeking to expand its sales team with the intent to grow deal flow, and accelerate the sales cycle."

Investor Ideas stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com - News that Inspires Big Investing Ideas

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this article featuring GCAN is a paid for article at Investorideas.com - learn more about costs and services https://www.investorideas.com/News-Upload/

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

Contact Investorideas.com

800-665-0411

Investorideas.com - #Cannabis and #Beverage Stock News: American Premium Water (OTC: $HIPH) Reports Acquisition of "Hydro-Nano" Energy #CBD and #THC Technology

#Cannabis and #Beverage Stock News: American Premium Water (OTC: $HIPH) Reports Acquisition of "Hydro-Nano" Energy #CBD and #THC Technology

Proprietary infusion formulation technology will boost market share

PLAYA VISTA, California - November 2, 2018 (Investorideas.com Newswire) Investorideas.com Newswire- American Premium Water Corporation (OTC Pink: HIPH) (the "Company") announces it has acquired proprietary "Hydro-Nano" Energy, CBD and THC-Cannabis infusion formulations. After months of negotiations, the Company has acquired proprietary infusion formulation technology that will boost its market share by allowing its product stand above any current or future competition. The transaction was completed with the issuance of restricted stock (with a minimum one year holding period)

This proprietary technology, which can be described as "Hydro-Nano" formulations, are infused with electrolyte energy, cannabidiol (CBD) and tetrahydrocannabinol (THC), which will give the Company a strategic and competitive advantage. These proprietary formulations are based on the hydro-nano technology that the Company has utilized for its original CBD water beverage, which allow for an absorption rate that is up to 90% higher than any other beverage in its class, enabling the infused formulations to immediately penetrate into the cells, by surpassing the bloodstream and creating a more immediate effect.

The Company is planning on utilizing the CBD formulation to create stronger, more potent beverages, utilizing 15-50mg of CBD, which will complement its existing CBD beverage line which currently uses 3mg per 16.9oz bottle. These formulations give the Company a foothold in three distinct categories: energy, CBD and THC. These categories will be the three pillars of the LALPINA brand going forward.

Historically, the Company had been working with third-party manufacturers, which created a number of logistical challenges, and exposed the Company to potentially compromising positions. Now, with this new technology, the Company will be immediately distinguished from its competitors, and hold a much brighter future.

"This acquisition is a gamechanger for us, as we expect it to propel the Company to new levels in the CBD infused beverage space, create a new category in the THC infused space, while driving shareholder value, through the sale of premium, uncompromised products, which has always been our primary objective." stated American Premium Water Corporation CEO Ryan Fishoff.

"This acquisition is the first of the CBD/cannabis-related acquisitions that the Company has previously announced. The way the industry is moving, one thing has become apparent to me; The technology that a company has is only as good as the marketing, branding, and distribution behind it. This Company excels in these areas; LALPINA has over 1 million followers on social media and several engaged distribution partners. This acquisition and the ones in the pipeline will address the "technology gap," which should take the Company to the next level. This acquisition alone could translate into tens of millions of dollars in annual topline sales. In addition, having the technology will open many different licensing opportunities to the Company, both domestically and internationally. In the coming weeks, the Company will roll out its larger strategy for the space as it provides more updates on ongoing discussions regarding the other transactions," stated Mr. Fishoff.

With the legalization of cannabis in Canada and further legalization measures on the ballot for four states in next week's election, the Company is actively pursuing distribution agreements for both of its CBD and THC beverages in the Canadian and U.S. markets. According to Arcview Market Research and its research partner BDS Analytics, spending on legal cannabis worldwide is expected to hit $57 billion by 2027, with $47 billion coming from North America, representing 82% of the total worldwide market. According to Statista, the U.S. beverage market, including alcoholic and non-alcoholic beverages, is $330 billion for the present year.

About American Premium Water Corp.

American Premium Water (OTC: HIPH) is a diversified luxury consumer products company focused on businesses in the health and beauty and biotech sectors. The company is focused on harnessing the powers of hydrogen and Nano technologies paired with cannabidiol (CBD) to treat health disorders and enhance quality of life. This business model aims to market emerging fashion brands by leveraging classic retail partners and incorporating disruptive block chain technologies to expand the retail footprint. The company's portfolio includes the LALPINA Hydro and LALPINA Hydro CBD brands (www.LalpinaInc.com), Gents, Worthy, and blockchain platform FashionCoinX (www.FashionCoinX.com).

Safe Harbor Notice
Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). American Premium Water Corporation cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. American Premium Water Corporation undertakes no obligation to revise these statements following the date of this news release. Additional details of the Company's business can be found in its public disclosures as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.

This press release is issued on behalf of the Board of Directors of American Premium Water Corporation

Corporate Communications Contact:

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com212.418.1217 Office
Editor@NetworkNewsWire.com

Disclaimer/disclosure- This third party news/article is published on the Investorideas.com Newswire - News that Inspires big ideas

Disclosure this is a paid for news release on the Investorideas.com newswire. Learn more about costs and our newswire service http://www.investorideas.com/News-Upload/

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp

Thursday, November 1, 2018

Investorideas.com - #Cannabisstocks: American Premium Water Corp. (OTC: $HIPH) Announces Acquisition of Proprietary #CBD and #THC Technology

#Cannabisstocks: American Premium Water Corp. (OTC: $HIPH) Announces Acquisition of Proprietary #CBD and #THC Technology

Company remains focused on acquiring more CBD-related technology while expanding its beverage offerings

PLAYA VISTA, California - November 1, 2018 (Investorideas.com Newswire) Investorideas.com Newswire- American Premium Water Corporation (OTC Pink: HIPH) (the "Company") announces it has acquired proprietary "Hydro-Nano" Energy, CBD and THC-Cannabis infusion formulations. After months of negotiations, the Company has acquired proprietary infusion formulation technology that will boost its market share by allowing its product stand above any current or future competition. The transaction was completed with the issuance of restricted stock (with a minimum one year holding period)

About American Premium Water Corp.

This press release is issued on behalf of the Board of Directors of American Premium Water Corporation

Corporate Communications Contact:

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com212.418.1217 Office
Editor@NetworkNewsWire.com

Disclaimer/disclosure- This third party news/article is published on the Investorideas.com Newswire - News that Inspires big ideas

Disclosure this is a paid for news release on the Investorideas.com newswire. Learn more about costs and our newswire service http://www.investorideas.com/News-Upload/

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp

Marijuana / Hemp Stocks

At Cannabisinvestorideas.com and Investorideas.com

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Investorideas.com - IBM talked and these Canadian Companies Listened: Blockchain & Cannabis: (NYSE: $IBM) (CSE: $UPCO.CN) (TSX-V: $DMGI.V) (TSX-V: $DNAX.V)

IBM talked and these Canadian Companies Listened: Blockchain & Cannabis: (NYSE: $IBM) (CSE: $UPCO.CN) (TSX-V: $DMGI.V) (TSX-V: $DNAX.V)

Point Roberts, WA and Delta, BC - November 1, 2018 (Investorideas.com Newswire) Investorideas.com, a leader in a leader in Blockchain content with its Bitcoin and Blockchain portals Bitcoinandblockchainstocks.com, Cryptocurrencyinvestorideas.com and Blockchaininvestorideas.com reports on blockchain companies deploying technology in the cannabis sector.

In 2017, IBM (NYSE: IBM) came out with a 3-page report offered to the BC government, on utilizing blockchain as a way to monitor and secure cannabis payment and tracking of the industry.

Blockchain's "relevance to regulating cannabis is similar to its many chain of custody applications in areas such as pharmaceutical distribution and food chains," IBM wrote in its submission. "The core to those supply chains is the same, assuring health and safety of consumers, preventing fraud and counterfeiting while creating a foundation of transparency upon which to base regulation."...

"This type of transparency would bring a new level of visibility and control to the provincial regulators and provide assurance to the multitude of cautious stakeholders regarding the way the management of a cannabis supply chain is rolled out within British Columbia," IBM said. (Source: Fortune Magazine: http://fortune.com/2017/11/07/ibm-blockchain-marijuana-cannabis/)

More info on Cannabis and BC government submissions: https://engage.gov.bc.ca/app/uploads/sites/121/2018/08/Cannabis-Regulation-in-B.C.-What-We-Heard.pdf

Fast-forward to 2018, with legalization finally here in Canada. A few companies have recently announced they listened to the advice of IBM and have started launching platforms and innovative ways with blockchain to help regulate and work with the cannabis industry.

The companies listed below have all recently announced their deployment and synergistic app technologies developing and moving into the cannabis space.

"DMG Blockchain Announces Global Supply Chain Management Platform for Cannabis

VANCOUVER, British Columbia, Oct. 16, 2018 -- DMG Blockchain Solutions Inc. (TSX-V: DMGI) (DMGGF:OTC US) (6AX.F) ("DMG" or the "Company"), a diversified blockchain and cryptocurrency company, is pleased to announce that development is now underway with our technology partner to build a global supply chain management platform with a focus on the legal cannabis industry. Deployment will begin in Canada, and subsequently expand globally.

The supply chain technology provides DMG and its partners with a "first mover" advantage as a global cannabis blockchain solution
DMG's platform will have the capability to provide immediate product traceability, as well as automating transactions and information flow among licensed producers, licensed distributors, regulators, retailers, shippers, and reporting and auditing systems
DMG's global technology partner has commercially deployed multiple blockchain-enabled supply chain management systems for Fortune 100 clients"

Full press here: https://finance.yahoo.com/news/dmg-blockchain-announces-global-supply-124959318.html

"Upco International Inc. Announces Synergy with the Multi-Billion Dollar Cannabis Sector in the Areas of Regulatory Compliance and Risk Mitigation

Vancouver, British Columbia - October 29, 2018 - Upco International Inc. (CSE: UPCO) (OTCQB: UCCPF) (FSE: U06) ("Upco") is pleased to announce that it is actively seeking to leverage its blockchain and eWallet technology to support the emerging and rapidly growing Cannabis industry. According to CEO Andrea Pagani, "Our advanced blockchain e-wallet will help to foster the security and legitimacy of this very significant sector, while also enhancing its supply chain efficiency. We are also exploring other potential synergies with the Cannabis industry, including reward programs."

With the highly regulated legalization of Cannabis in Canada and 22 European countries, there is a need, and opportunity, to be able to securely track and report on aspects of transactions that are subject to regulation, including for example, the age and identity of the purchaser."

Highlights from UPCO app technology

Integration between our bank (Emoney) and our eWallet, will position Upco to provide the Cannabis sector with a convenient, robust, and secure financial solution that provides Upco merchants with:

Reliable customer verification based on a secure onboarding process managed by eMoney. This authentication will mitigate the risk of selling products to non-legitimate and / or under-age persons.
The ability, via their own POS systems, to track purchases (e.g. volumes, categories) against specific, reliably authenticated and age-verified customers.

Features, which will ultimately benefit both parties to a transaction (vendors and customers) include:

Realtime transfer of fiat currency from the customer's eWallet to the vendor.
A debit Mastercard to use as an extension of the eWallet to pay any approved Mastercard merchant worldwide.
Access to money on a 24 x7 basis, year-round.

Full press release here: https://finance.yahoo.com/news/upco-international-inc-announces-synergy-130000054.html

"It's Here: BLOCKStrain's Revolutionary Genome to Sale Software Goes Live

VANCOUVER , Oct. 24, 2018 - BLOCKSTRAIN TECHNOLOGY CORP. (the "Company" or "BLOCKStrain") (TSXV:DNAX.V) (OTC PINK: BKKSF) and WeedMD Inc. ("WeedMD") (TSX-V:WMD) (WDDMF) (4WE.F) are pleased to announce the formal launch of the BLOCKStrain proprietary genome tracking software following the collection of WeedMD's cannabis plant DNA last week. BLOCKStrain is now generating its first revenue with the launch of the commercial version of the software offering with WeedMD as the Company's first commercial client."

Full press release here: https://finance.yahoo.com/news/blockstrains-revolutionary-genome-sale-software-141800673.html

Investorideas.com features content for Bitcoin, Blockchain and Digital Currency Stocks and ICO's at Cryptocurrencyinvestorideas.com and Investorideas.com

View our growing Bitcoin, Blockchain and Digital Currency Stocks Directory

Join our LinkedIn Group Blockchain and Digital Currency Stocks and ICO's - Latest News and Commentary https://www.linkedin.com/groups/13560073

About Investorideas.com - News that Inspires Big Ideas

www.Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors. Sectors we cover include tech (AI, drones, internet of things) , payments, crypto and blockchain, biotech, mining, energy, renewable energy, water , marijuana and hemp stocks, food and beverage, defense and security (biometrics/cyber) ,Latin America, sports, entertainment, luxury brands and gaming. http://www.investorideas.com/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: UPCO International Inc. (CSE:UPCO ) is a paid PR, media, news publishing and social media client on Investorideas. (Options - exercisable for one year as of December 26, 2017)

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894 . Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Contact Investorideas.com

800 665 0411

Wednesday, October 31, 2018

Investorideas.com - Viridian Cannabis Deal Tracker for the Week Ended October 26, 2018

Investorideas.com - Viridian Cannabis Deal Tracker for the Week Ended October 26, 2018

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - #Cannabisstocks: Freedom Leaf Inc. (OTCQB: FRLF) Exceeds Revenue Guidance by 47%, Fiscal First Quarter Revenue Projected to Exceed Approximately $600,000 as Tierra Science Launches

Investorideas.com - #Cannabisstocks: Freedom Leaf Inc. (OTCQB: FRLF) Exceeds Revenue Guidance by 47%, Fiscal First Quarter Revenue Projected to Exceed Approximately $600,000 as Tierra Science Launches

Get the latest Cannabis and Hemp stock news from www.investorideas.com

about Investorideas.com

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .